Clinical trial

Prevention of Acute Exacerbation in Subjects With COPD by Bacterial Decolonization in Lower Respiratory Tract

NCT03449459

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIETARY_SUPPLEMENT · Unmapped registry intervention oral probiotics Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention aerosol inhaled amikacin Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention combined vaccination Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Prevention of Acute Exacerbation in Subjects With COPD by Bacterial Decolonization in Lower Respiratory Tract

Design: INTERVENTIONAL · Status: COMPLETED · Phase: EARLY_PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-12-01

PhaseEARLY_PHASE1

Conditions

Chronic Obstructive Pulmonary Disease (COPD)verified · MONDO: chronic obstructive pulmonary disease

Interventions

oral probioticsDIETARY_SUPPLEMENT

aerosol inhaled amikacinDRUG

combined vaccinationBIOLOGICAL

Sponsors & collaborators

Shanghai Zhongshan Hospitallead sponsor

The First Affiliated Hospital of Guangzhou Medical Universitycollaborator

Ruijin Hospitalcollaborator

Mapped research locations

ShanghaiShanghai Municipality, China2 GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03449459 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.